ইউরোপীয় ইউনিয়ন - স্পেনীয় - EMA (European Medicines Agency)

amgen europe bv - sotorasib - carcinoma, pulmón no microcítico - agentes antineoplásicos - lumykras as monotherapy is indicated for the treatment of adults with advanced non-small cell lung cancer (nsclc) with kras g12c mutation and who have progressed after at least one prior line of systemic therapy.

ইউরোপীয় ইউনিয়ন - স্পেনীয় - EMA (European Medicines Agency)

merck europe b.v. - tepotinib hydrochloride monohydrate - carcinoma, pulmón no microcítico - agentes antineoplásicos - tepmetko as monotherapy is indicated for the treatment of adult patients with advanced non-small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal-epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum-based chemotherapy.

ইউরোপীয় ইউনিয়ন - স্পেনীয় - EMA (European Medicines Agency)

mylan pharmaceuticals limited - teriflunomide - la esclerosis múltiple remitente-recurrente - inmunosupresores - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).

ইউরোপীয় ইউনিয়ন - স্পেনীয় - EMA (European Medicines Agency)

accord healthcare s.l.u. - teriflunomide - la esclerosis múltiple remitente-recurrente - los inmunosupresores selectivos de inmunosupresores - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).

ইউরোপীয় ইউনিয়ন - স্পেনীয় - EMA (European Medicines Agency)

akebia europe limited - vadadustat - renal insufficiency, chronic; anemia - preparaciones antianémicas - vafseo is indicated for the treatment of symptomatic anaemia associated with chronic kidney disease (ckd) in adults on chronic maintenance dialysis.

স্পেন - স্পেনীয় - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

aurovitas spain, s.a.u. - leflunomida - comprimido recubierto con pelÍcula - 10 mg - leflunomida 10 mg - leflunomida

স্পেন - স্পেনীয় - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

aurovitas spain, s.a.u. - leflunomida - comprimido recubierto con pelÍcula - 20 mg - leflunomida 20 mg - leflunomida

স্পেন - স্পেনীয় - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

laboratorio stada s.l. - lapatinib - comprimido recubierto con pelÍcula - 250 mg - lapatinib 250 mg - lapatinib

পিরু - স্পেনীয় - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

suiza medical import s.a.c. - polvo para concentrado para solucion para perfusion - por vial 4.00 mg - topotecán